Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a)

Karol Wielgus; Renata Rajtar-Salwa; Wojciech Zasada; Bernadeta Chyrchel; Stanisław Bartuś; Artur Dziewierz; Beata Bobrowska

doi:10.5114/aic.2026.161982

Full text

2/2026 vol. 22

Image in intervention

Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a)

Karol Wielgus ¹

,

Renata Rajtar-Salwa ^{1, 2}

,

Wojciech Zasada ^{1, 3}

,

Bernadeta Chyrchel ^{1, 2}

,

Stanisław Bartuś ^{1, 2}

,

Artur Dziewierz ^{1, 2}

,

Beata Bobrowska ¹

Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland
Second Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
KCRI, Krakow, Poland

Adv Interv Cardiol 2026; 22, 2 (84): 312–314

DOI: https://doi.org/10.5114/aic.2026.161982

Data publikacji online: 2026/07/09

Article file

Severe ischemic.pdf

AMA

Wielgus K, Rajtar-Salwa R, Zasada W, et al. Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a). Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2026;22(2):312-314. doi:10.5114/aic.2026.161982.

APA

Wielgus, K., Rajtar-Salwa, R., Zasada, W., Chyrchel, B., Bartuś, S., & Dziewierz, A. et al. (2026). Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a). Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 22(2), 312-314. https://doi.org/10.5114/aic.2026.161982

Chicago

Wielgus, Karol, Renata Rajtar-Salwa, Wojciech Zasada, Bernadeta Chyrchel, Stanisław Bartuś, Artur Dziewierz, and Beata Bobrowska. 2026. "Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a)". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 22 (2): 312-314. doi:10.5114/aic.2026.161982.

Harvard

Wielgus, K., Rajtar-Salwa, R., Zasada, W., Chyrchel, B., Bartuś, S., Dziewierz, A., and Bobrowska, B. (2026). Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a). Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 22(2), pp.312-314. https://doi.org/10.5114/aic.2026.161982

MLA

Wielgus, Karol et al. "Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a)." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 22, no. 2, 2026, pp. 312-314. doi:10.5114/aic.2026.161982.

Vancouver

Wielgus K, Rajtar-Salwa R, Zasada W, Chyrchel B, Bartuś S, Dziewierz A et al. Severe ischemic cardiomyopathy in a young patient: double genetic burden of familial hypercholesterolemia and elevated lipoprotein(a). Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2026;22(2):312-314. doi:10.5114/aic.2026.161982.

Hauguel-Moreau M, Aïdan V, Hergault H, et al. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome. Arch Cardiovasc Dis 2022; 115: 87-95.
Kamstrup PR, Benn M, Tybjaerg-Hansen A, et al. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008; 117: 176-84.
Alonso R, Argüeso R, Álvarez-Baños P, et al. Familial hypercholesterolemia and lipoprotein(a): two partners in crime? Curr Atheroscler Rep 2022; 24: 427-34.
Paquette M, Cariou B, Guay SP, et al.; French REgistry of Familial hypERCHOLesterolemia (REFERCHOL) investigators. Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemia. J Clin Lipidol 2025; 19: 1264-72.
Bobrowska B, Rajtar-Salwa R, Zasada W, et al. Primary care providers-initiated screening for familial hypercholesterolemia: a model proposed based on the Kordian primary prevention program for cardiovascular diseases. Pol Arch Intern Med 2026; 136: 17232.

Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

SUBMIT YOUR PAPER

Share

Indexed in

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications